Avalo Therapeutics (AVTX) EPS (Basic) (2014 - 2026)
Avalo Therapeutics posted quarterly EPS (Basic) of -$0.98 for Q1 2026, up 21.6% year-on-year from -$0.81 in Q1 2025, and down 164.86% on a QoQ basis from -$0.37 in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of EPS (Basic) data on file, last reported at -$0.98 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 21.6% year-over-year to -$0.98; the trailing twelve-month figure through Mar 2026 stood at -$5.46 (down 36.16% YoY), and the FY2025 full-year result was -$5.84, up 26.45% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.98, down from -$0.37 in the prior quarter.
- Across five years, EPS (Basic) topped out at $117.47 in Q4 2023 and bottomed at -$1059.6 in Q4 2022.
- The 5-year median for EPS (Basic) is -$1.92 (2025), against an average of -$86.34.
- Peak annual rise in EPS (Basic) reached 116.35% in 2022, while the deepest fall reached 54802.07% in 2022.
- A 5-year view of EPS (Basic) shows it stood at -$1059.6 in 2022, then jumped by 111.09% to $117.47 in 2023, then plunged by 106.77% to -$7.95 in 2024, then jumped by 95.35% to -$0.37 in 2025, then tumbled by 164.86% to -$0.98 in 2026.
- The last three EPS (Basic) figures came in at -$0.98 (Q1 2026), -$0.37 (Q4 2025), and -$2.19 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -0.37 |
| Sep 30, 2025 | -2.19 |
| Jun 30, 2025 | -1.92 |
| Mar 31, 2025 | -1.25 |
| Dec 31, 2024 | -7.95 |
| Sep 30, 2024 | 0.98 |
| Jun 30, 2024 | 4.21 |
| Mar 31, 2024 | -141.14 |
| Dec 31, 2023 | 117.47 |
| Sep 30, 2023 | -26.83 |
| Jun 30, 2023 | -140.73 |
| Mar 31, 2023 | -204.00 |
| Dec 31, 2022 | -1,059.61 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | -1.38 |
| Mar 31, 2022 | -2.35 |
| Dec 31, 2021 | -1.93 |
| Sep 30, 2021 | -2.08 |
| Jun 30, 2021 | -2.12 |
| Mar 31, 2021 | -1.61 |
| Dec 31, 2020 | -3.64 |
| Sep 30, 2020 | -0.83 |
| Jun 30, 2020 | -0.96 |
| Mar 31, 2020 | -1.70 |
| Dec 31, 2019 | -1.10 |
| Sep 30, 2019 | -0.35 |
| Jun 30, 2019 | -0.23 |
| Mar 31, 2019 | -0.13 |
| Dec 31, 2018 | -0.15 |
| Sep 30, 2018 | -0.75 |
| Jun 30, 2018 | -0.19 |
| Mar 31, 2018 | -0.12 |
| Dec 31, 2017 | -0.11 |
| Sep 30, 2017 | 0.52 |
| Jun 30, 2017 | -0.14 |
| Mar 31, 2017 | -0.19 |
| Dec 31, 2016 | -0.18 |
| Sep 30, 2016 | -0.70 |
| Jun 30, 2016 | -0.41 |
| Mar 31, 2016 | -0.59 |
| Dec 31, 2015 | -0.53 |
| Sep 30, 2015 | -1.06 |
| Jun 30, 2015 | -4.48 |
| Mar 31, 2015 | -4.98 |
| Dec 31, 2014 | -3.88 |
| Sep 30, 2014 | 10.35 |